Study to Evaluate the Acute Bioavailability of EPA and DHA From a DietarySupplement in Healthy Men and Women

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Healthy
Interventions
OTHER

Wax Ester Marine Oil

Wax ester marine oil (Calanus oil; 4 g providing 260 mg EPA and 156 mg DHA; 8 capsules) consumed once, in clinic, at t=0.

OTHER

Ethyl Ester Marine Oil

Ethyl ester (EE) marine oil (Lovaza OM3 EE; 1 g providing 465 mg EPA and 375 mg DHA; 1 capsule), consumed once, in clinic, at t=0

Trial Locations (1)

60101

Biofortis Clinical Research, Addison

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Biofortis Clinical Research, Inc.

INDUSTRY

lead

Calanus

INDUSTRY

NCT02865044 - Study to Evaluate the Acute Bioavailability of EPA and DHA From a DietarySupplement in Healthy Men and Women | Biotech Hunter | Biotech Hunter